Page last updated: 2024-12-05

2-iodophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Iodophenol is an organic compound with the formula C6H4IOH. It is a colorless solid that is used as a precursor to other organic compounds. It can be synthesized by the reaction of phenol with iodine in the presence of a base. 2-Iodophenol is a versatile building block for the synthesis of various pharmaceutical and agricultural chemicals. It is also used as a reagent in organic synthesis. It is a useful intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. Its importance stems from its ability to act as an electrophilic substrate in various reactions, allowing for the construction of complex molecules. It is studied for its potential applications in medicine, agriculture, and materials science.'
```

Cross-References

ID SourceID
PubMed CID10784
CHEMBL ID225564
CHEBI ID16706
SCHEMBL ID5720
MeSH IDM0057481

Synonyms (55)

Synonym
AC-4390
2-jodfenol
f27l34a8b9 ,
unii-f27l34a8b9
o-jodfenol
4-06-00-01070 (beilstein handbook reference)
2-iodo-phenol
o-jodphenol
2-jodphenol
CHEBI:16706 ,
nsc 9245
2-jodfenol [czech]
brn 1855300
iodophenol
o-jodfenol [czech]
einecs 208-569-9
nsc-9245
wln: qr bi
phenol, o-iodo-
o-iodophenol
phenol, 2-iodo-
nsc9245
inchi=1/c6h5io/c7-5-3-1-2-4-6(5)8/h1-4,8
C01874
533-58-4
2-iodophenol ,
2-iodophenol, 98%
CHEMBL225564
I0460
30587-23-6
AKOS009156984
A829536
2-iodanylphenol
STL280542
FT-0632327
phenol, iodo-
BP-21314
2-iodo phenol
SCHEMBL5720
o-iodophenol [mi]
DTXSID5052175
AM87042
J-200045
STR06375
PS-7876
mfcd00013963
CS-W008896
6x8 ,
2-iodophenol (2ip)
bdbm217397
SY005097
Q27102035
EN300-39648
H11264
Z384970702
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
iodophenol
2-halophenolA halophenol in which the halogen atom is bonded to the carbon atom adjacent to the C-OH group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Iodotyrosine deiodinaseHaliscomenobacter hydrossis DSM 1100Kd738.50000.09004.14508.2000AID1802488
Iodotyrosine deiodinase 1Homo sapiens (human)Kd738.50000.09004.14508.2000AID1802488
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
tyrosine metabolic processIodotyrosine deiodinase 1Homo sapiens (human)
thyroid hormone metabolic processIodotyrosine deiodinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
protein bindingIodotyrosine deiodinase 1Homo sapiens (human)
FMN bindingIodotyrosine deiodinase 1Homo sapiens (human)
iodotyrosine deiodinase activityIodotyrosine deiodinase 1Homo sapiens (human)
oxidoreductase activityIodotyrosine deiodinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
nucleoplasmIodotyrosine deiodinase 1Homo sapiens (human)
plasma membraneIodotyrosine deiodinase 1Homo sapiens (human)
cytoplasmic vesicle membraneIodotyrosine deiodinase 1Homo sapiens (human)
plasma membraneIodotyrosine deiodinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID282834Activity against caspase-mediated apoptosis in mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID282833Activity against caspase-mediated apoptosis in mouse L1210 cells at 0.1 mM2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID1802488IYD Binding Assay from Article 10.1021/acs.biochem.6b01308: \\Active Site Binding Is Not Sufficient for Reductive Deiodination by Iodotyrosine Deiodinase.\\
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's1 (7.14)18.2507
2000's5 (35.71)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.67 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]